re: Ann: iSonea Investor Update Presentation ...
So I guess we're not going to talk about that elephant in the virtual room....? Ok I'm going to do it. No mention of the 510k or US roadmap whatsoever. Really? The FDA doesn't come up once for discussion; not even in the fine print. Pretty lame for an 'investor update'.
The only fresh material I could see, was talk about the irrelevance of earnings. Not boding well for the upcoming quarterly.
Who else is missing MT right now?
Sad face.
ISN Price at posting:
37.5¢ Sentiment: None Disclosure: Held